Published in J Clin Pathol on February 01, 1999
Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol (2010) 1.84
Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis (2003) 1.50
Rhesus monkey gastric mucins: oligomeric structure, glycoforms and Helicobacter pylori binding. Biochem J (2004) 1.14
Role of mucin Lewis status in resistance to Helicobacter pylori infection in pediatric patients. Helicobacter (2010) 0.95
Commensal ocular bacteria degrade mucins. Br J Ophthalmol (2002) 0.90
Enzyme-labeled Antigen Method: Development and Application of the Novel Approach for Identifying Plasma Cells Locally Producing Disease-specific Antibodies in Inflammatory Lesions. Acta Histochem Cytochem (2016) 0.75
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
A human model of gastric carcinogenesis. Cancer Res (1988) 6.52
DIAMINE METHODS FOR DIFFERENTIALING MUCOSUBSTANCES HISTOCHEMICALLY. J Histochem Cytochem (1965) 4.55
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev (1997) 2.68
Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol (1995) 2.64
Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res (1996) 2.56
Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol (1994) 2.16
Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst (1976) 2.14
Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res (1990) 2.02
Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res (1990) 1.62
Sulphomucins and precancerous lesions of the human stomach. Histopathology (1980) 1.40
Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology (1996) 1.29
Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev (1996) 1.25
N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. Carcinogenesis (1997) 1.15
Subtypes of intestinal metaplasia and Helicobacter pylori. Gut (1992) 1.00
Evidence for arylamine N-acetyltransferase activity in the bacterium Helicobacter pylori. Toxicol Lett (1997) 0.85
Tissue staining for Helicobacter pylori in intestinal metaplasia: correlation with its extension and histochemical subtypes. Ital J Gastroenterol (1996) 0.81
Campylobacter pylori and gastric antral intestinal metaplasia. Gastroenterology (1988) 0.80
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci U S A (2001) 4.80
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35
Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology (1998) 4.30
A model for gastric cancer epidemiology. Lancet (1975) 4.02
Transmission of Helicobacter pylori among siblings. Lancet (2000) 3.78
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Long term follow up of patients treated for Helicobacter pylori infection. Gut (2005) 3.09
Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol (1989) 2.81
Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology (1990) 2.64
Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res (1996) 2.56
Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev (1993) 2.53
Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol (1986) 2.52
Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst (1970) 2.35
Passive smoking and lung cancer. Lancet (1983) 2.27
Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst (1976) 2.14
The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol (1995) 2.10
Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst (1976) 2.09
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA (1994) 2.04
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol (1993) 1.77
Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1996) 1.75
Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer (1968) 1.73
Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst (1993) 1.72
Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol (1996) 1.69
Precursors of gastric and esophageal cancer. Cancer (1982) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis (2007) 1.62
Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer (1999) 1.60
Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol (1985) 1.59
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst (2000) 1.55
High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol (1992) 1.54
Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol (1988) 1.54
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Is gastric carcinoma an infectious disease? N Engl J Med (1991) 1.50
Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.48
Gastric carcinoma in the young. Cancer (1987) 1.47
p53 alteration in gastric precancerous lesions. Am J Pathol (1994) 1.45
Prolonged achlorhydria and gastric neoplasia: is there a causal relationship? Gastroenterology (1993) 1.45
Geographic pathology of latent prostatic carcinoma. Int J Cancer (1982) 1.44
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst (1992) 1.43
The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer (1984) 1.41
The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci U S A (1991) 1.40
Histopathology of gastric dysplasias: correlations with gastric juice chemistry. Am J Surg Pathol (1979) 1.40
Precursor lesions of oesophageal cancer in young people in a high-risk population in China. Lancet (1989) 1.38
Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer (1997) 1.32
Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol (2001) 1.26
Developments in the epidemiology of stomach cancer over the past decade. Cancer Res (1975) 1.26
CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect (2009) 1.25
Gastric dysplasia. Significance and pathologic criteria. Cancer (1984) 1.23
Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst (1980) 1.23
The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer (1977) 1.23
Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev (1994) 1.22
Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol (1995) 1.19
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Am J Gastroenterol (2001) 1.18
A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer (1992) 1.17
The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res (1980) 1.16
Epidemiologic patterns of Hodgkin's disease. Int J Cancer (1971) 1.15
Cancer of the colon and rectum and adenomatous polyps. A review of epidemiologic findings. Cancer (1971) 1.14
Occupational exposure to environmental tobacco smoke. JAMA (1996) 1.13
Risk factors for maternal mortality: a case-control study in Dakar hospitals (Senegal). Afr J Reprod Health (1997) 1.13
Gastric cancer in Colombia. IV. Nitrite and other ions in gastric contents of residents from a high-risk region. J Natl Cancer Inst (1979) 1.12
Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst (1985) 1.12
Epidemiological correlations between diet and cancer frequency. Cancer Res (1981) 1.12
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci (1993) 1.10
The epidemiology of large-bowel cancer. Adv Cancer Res (1978) 1.10
Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv (1989) 1.10
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev (1996) 1.10
Helicobacter pylori and gastric atrophy--cancer paradoxes. J Natl Cancer Inst (1995) 1.09
Pathology of gastric carcinoma in Japanese populations: comparisons between Miyagi prefecture, Japan, and Hawaii. J Natl Cancer Inst (1973) 1.08
Report of an Amsterdam working group on Barrett esophagus. Virchows Arch (2003) 1.08
Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr (1997) 1.07
Arteritis of the aorta and its major branches. Am Heart J (1970) 1.07
Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res (1995) 1.06
Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience. Cancer (1992) 1.06
Crohn's disease presenting as septic thrombophlebitis of the portal vein (pylephlebitis): case report and review of the literature. Am J Gastroenterol (1999) 1.06
Diet and chronic atrophic gastritis: a case-control study. J Natl Cancer Inst (1986) 1.05
Morbidity and mortality from cancer in Cali, Colombia. J Natl Cancer Inst (1966) 1.05
Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol (1999) 1.05
Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter (1997) 1.04
Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol (1995) 1.04
Social class differences among patients with large-bowel cancer in Cali, Colombia. J Natl Cancer Inst (1975) 1.02
Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. Int J Epidemiol (1998) 1.02
Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol (1994) 1.02
Food groups and risk of squamous cell carcinoma of the oesophagus: a case-control study in Uruguay. Br J Cancer (2003) 1.02
Morbidity from cancer in La Paz, Bolivia. Int J Cancer (1981) 1.01
Hot maté drinking and precancerous lesions of the oesophagus: an endoscopic survey in southern Brazil. Int J Cancer (1987) 1.00
Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells. Infect Immun (2008) 1.00
Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer (1988) 1.00
Carcinogenic and other adverse effects of procarbazine in nonhuman primates. Cancer Res (1978) 1.00
Lung cancer in motor exhaust-related occupations. Am J Ind Med (1989) 1.00
Nitrate and gastric cancer risks. Nature (1985) 0.99
Helicobacter mustelae-associated gastric MALT lymphoma in ferrets. Am J Pathol (1997) 0.99
Diet and gastric cancer: nutrition survey in a high-risk area. J Natl Cancer Inst (1983) 0.99
Atherosclerosis and polyps of the colon. Quantification of precursors of coronary heart disease and colon cancer. J Chronic Dis (1982) 0.99
Dietary vitamins A and C and lung cancer risk in Louisiana. Cancer (1988) 0.98